Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Moderna (NasdaqGS:MRNA) with a Neutral recommendation. Analyst Price Forecast Suggests 62.09% Upside As of March 4, 2025, the ...

A two-story lab building in East Cambridge is proposed for redevelopment at six stories in a process called “contract zoning” ...

Cambridge, Mass.-based Moderna MRNA had a net loss of $1.1 billion for the quarter, or $2.91 a share, after earnings of $217 million, or 55 cents a share, in the year-earlier period. Back To Top ...

The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...

mRESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Friday reported a loss of $1.12 billion in its fourth quarter. On a per-share basis, the Cambridge, Massachusetts-based ...

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...